Zavegepant
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
Zavegepant and lactation: What the pharmacokinetic data suggests.
Journal: Headache
Published: January 13, 2026
Cost-effectiveness analysis of ubrogepant, rimegepant, and zavegepant for acute migraine treatment vs usual care.
Journal: The American journal of managed care
Published: November 25, 2025
Early Experience Treating Vestibular Migraine With Small Molecule CGRP Antagonists.
Journal: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
Published: October 22, 2025
Gepants: targeting the CGRP pathway for migraine relief.
Journal: Frontiers in pharmacology
Published: September 18, 2025
Patient-Reported Outcomes During the Acute Treatment of Migraine with Zavegepant Nasal Spray: Results from a 52-Week, Open-Label Study.
Journal: Pain and therapy
Published: July 15, 2025
Safety analysis of gepants for migraine treatment: A pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database.
Journal: Headache
Published: July 08, 2025
Integrating gepants into clinical practice for the acute treatment of migraine.
Journal: Headache
Published: June 11, 2025
Clinical evaluation of zavegepant for the acute treatment of migraine.
Journal: Journal of managed care & specialty pharmacy
Published: May 30, 2025
Adverse events associated with gepants: a pharmacovigilance analysis based on the FDA adverse event reporting system.
Journal: The journal of headache and pain
Published: May 23, 2025
Last Updated: 04/28/2026